SCHEMBL6188461

SCHEMBL6188461

Fc1cc(CNCCc2ccc(Cl)c(Cl)c2)ccc1Oc1cnccn1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ROCK1 Q13464 1/20 0.46
SIGMAR1 Q99720 2/20 0.41
PPARD Q03181 1/20 0.40
PLK1 P53350 1/20 0.40
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
P2RX3 P56373 6/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3696154 0.81 CYP2D6 (0.44) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL27549039 0.80 PPARD (0.44) PPARDCARM1PRMT6KDM4EALDH1A1
SCHEMBL2857170 0.71 HTR5A (0.58) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL2854484 0.70 CYP1A2 (0.68) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL31132631 0.69 HSPB1 (0.50) KDM4EMEN1KMT2A
SCHEMBL3701411 0.67 OPRM1 (0.48) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL1397549 0.66 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL31132488 0.65 MAPT (0.44) KDM4EMEN1KMT2A
SCHEMBL3699258 0.65 OPRM1 (0.71) CYP2D6CYP2C9CYP2C19ROCK1
SCHEMBL11089154 0.65 CYP1A2 (0.66) CYP1A2CYP2D6CYP2C9CYP2C19ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562595-A1 DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-08-17 EP disclosed
WO-2004026305-A1 DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST ELI LILLY AND COMPANY (US) 2004-04-01 WO disclosed